JPRN-UMIN000013881尚未招募2 期
Phase II Study to evaluate efficacy and safety of Lenalidomide maintenance therapy for multiple myeloma patients under bortezomib treatment - L-Defense study
ational Defense Medical College0 个研究点目标入组 29 人开始时间: 2014年5月5日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 29
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients who are pregnant or lactating. 2. Patients who had been determined ineligible for any reason by physician. 3. Patients who have not achieved PR with bortezomib therapy as initial treatment. 4. Patients who progressed in disease status less than PR after the initial response.
研究者
相似试验
招募中
2 期
uPBSCT with PTCY for ATadult T-cell leukemia/lymphomaJPRN-jRCTs031200375Fukuda Takahiro24
招募中
不适用
Phase II study to evaluate efficacy and safety of retherapy with bendamustine and rituximab regimens in patients with relapsed/refractory indolent B-cell lymphomas and mantle cell lymphomasJPRN-UMIN000011152B-SRIM Study Group38
进行中（未招募）
1 期
Study to evaluate efficacy and safety of sunitinib in patients with renal cell carcinoma who have progressed to first-line immunotherapy treatmentmetastatic renal clear cell carcinomaMedDRA version: 19.1Level: LLTClassification code 10038416Term: Renal clear cell carcinomaSystem Organ Class: 100000004864EUCTR2016-004011-12-ESSOGUG (Spanish Oncology Genitourinary Group)
招募中
2 期
A phase II study to reveal safety and efficacy of TM5509 in cord blood transplantatioCord Blood TransplantationJPRN-UMIN000018180Tohoku university school of medicine, molecular medicine and therapy, Toshio Miyata21
尚未招募
2 期
A phase 2 study to evaluate safety and efficacy of laparoscopic sleeve gastrectomy with duodenojejunal bypass for obesity with diabetes mellitusMorbid obesity with diabetes mellitusJPRN-UMIN000035537Kansai Medical University Hospital33